SCI & TECH● LOW1h ago · Oct 11, 2026, 2:15 AM
Spirit of Hong Kong Awards: biotech firm eyes cervical cancer test breakthrough
South China Morning Post · east asia
Hong Kong biotech entrepreneur Ricky Chiu Yin-to is seeking to make cervical cancer screening easier through urine-based HPV testing, using sample-concentration technology developed by his company. His company, Phase Scientific, made its name during the Covid-19 pandemic through its rapid antigen test, Indicaid. The product received US emergency-use authorisation in July 2021, was used in Hong Kong community testing and sold in more than 30 countries. At the start of the pandemic, the firm...
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Sci & Tech
SCI & TECH2h agoHangzhou is doubling down on tech – minus the viral hypeSouth China Morning PostSCI & TECH3h agoAI capitalism has become a continuously expanding ecosystemClarínSCI & TECH4h agoIt's official | Texas confirmed that air taxis will start operating from this dateClarínSCI & TECH6h agoIn AI, India’s choice needn’t be between a US leash or Chinese hookSouth China Morning Post